✦ LIBER ✦

Effect of combined hypotensive and hypolipidemic therapy on CHD metabolic risk factors in NIDDM patients

Book ID: 118630885
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 150 KB
Volume: 3
Category: Article
ISSN: 1567-5688
DOI: 10.1016/s1567-5688(02)80330-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of combined therapy with statins

Effect of combined therapy with statins and hypotensive drugs of different class on global coronary risk and insulin resistance in metabolic syndrome patients

✍ Mamedov, M.; Kosmatova, O.; Khadipash, L.; Perova, N.; Oganov, R. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Effect of Metabolic Syndrome Factors and

Effect of Metabolic Syndrome Factors and Insulin Resistance on Ezetimibe/Simvastatin and Atorvastatin Treatment Efficacy in Patients with Metabolic Syndrome and Moderately High/High CHD Risk

✍ Jeffrey B. Rosen; Christie M. Ballantyne; Scott M. Grundy; Willa A. Hsueh; Hans- 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 264 KB

METABOLIC RISK FACTORS AND THE IMPACT OF

METABOLIC RISK FACTORS AND THE IMPACT OF MEDICAL THERAPY ON THE MANAGEMENT OF NEPHROLITHIASIS IN OBESE PATIENTS

✍ EKERUO, WESLEY O.; TAN, YEH HONG; YOUNG, MATTHEW D.; DAHM, PHILIPP; MALONEY, MIC 📂 Article 📅 2004 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 327 KB

Prevalence of the metabolic syndrome in

Prevalence of the metabolic syndrome in postmenopausal korean women and the effects of hormone therapy on metabolic risk factors

✍ S. Kim; S. Kim; C. Suh; Y.M. Choi; J.G. Kim; S.Y. Moon 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 83 KB

D76 Effects, on blood pressure and cardi

D76 Effects, on blood pressure and cardiovascular risk factors of adding doxazosin to the current hypotensive therapy in patients with non-controlled hypertension

✍ J. Latorre; L. Garcia; M.E. Garcia; F. Gil; J. Miró; A. Soria; J. Vergara 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 133 KB

The effect of combined therapy with etof

The effect of combined therapy with etofibrate and amlodipine or indapamide on HDL phospholipid in patients with metabolic syndrome

✍ Paramonova, I.; Jasminova, V.; Ozerova, I.; Kosmatova, O.; Mamedov, M.; Perova, 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 177 KB